BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22848398)

  • 61. APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
    Li Z; Abraham BJ; Berezovskaya A; Farah N; Liu Y; Leon T; Fielding A; Tan SH; Sanda T; Weintraub AS; Li B; Shen S; Zhang J; Mansour MR; Young RA; Look AT
    Leukemia; 2017 Oct; 31(10):2057-2064. PubMed ID: 28260788
    [TBL] [Abstract][Full Text] [Related]  

  • 62. NKX3.1 potentiates TNF-alpha/CHX-induced apoptosis of prostate cancer cells through increasing caspase-3 expression and its activity.
    Pengju Z; Weiwen C; Aiying W; Zhaobo C; Nana N; Zhaoqin H; Qingwei L; Anli J
    Biochem Biophys Res Commun; 2010 Jul; 398(3):457-61. PubMed ID: 20599703
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance.
    Rosales-Aviña JA; Torres-Flores J; Aguilar-Lemarroy A; Gurrola-Díaz C; Hernández-Flores G; Ortiz-Lazareno PC; Lerma-Díaz JM; de Celis R; González-Ramella Ó; Barrera-Chaires E; Bravo-Cuellar A; Jave-Suárez LF
    J Exp Clin Cancer Res; 2011 Dec; 30(1):112. PubMed ID: 22185299
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.
    He WW; Sciavolino PJ; Wing J; Augustus M; Hudson P; Meissner PS; Curtis RT; Shell BK; Bostwick DG; Tindall DJ; Gelmann EP; Abate-Shen C; Carter KC
    Genomics; 1997 Jul; 43(1):69-77. PubMed ID: 9226374
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
    Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
    Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
    Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY
    Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
    Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
    J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
    Ferrando AA; Herblot S; Palomero T; Hansen M; Hoang T; Fox EA; Look AT
    Blood; 2004 Mar; 103(5):1909-11. PubMed ID: 14604958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia.
    Goossens S; Peirs S; Van Loocke W; Wang J; Takawy M; Matthijssens F; Sonderegger SE; Haigh K; Nguyen T; Vandamme N; Costa M; Carmichael C; Van Nieuwerburgh F; Deforce D; Kleifeld O; Curtis DJ; Berx G; Van Vlierberghe P; Haigh JJ
    Blood; 2017 Feb; 129(8):981-990. PubMed ID: 28069602
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Hematopoietic TALE-Code Shows Normal Activity of IRX1 in Myeloid Progenitors and Reveals Ectopic Expression of IRX3 and IRX5 in Acute Myeloid Leukemia.
    Nagel S; Pommerenke C; Meyer C; MacLeod RAF
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328612
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells.
    Simmons SO; Horowitz JM
    Biochem J; 2006 Jan; 393(Pt 1):397-409. PubMed ID: 16201967
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
    Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B
    Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NKL homeobox gene activities in normal and malignant myeloid cells.
    Nagel S; Scherr M; MacLeod RAF; Pommerenke C; Koeppel M; Meyer C; Kaufmann M; Dallmann I; Drexler HG
    PLoS One; 2019; 14(12):e0226212. PubMed ID: 31825998
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distinct regulatory elements mediate the dynamic expression pattern of Nkx3.1.
    Chen H; Mutton LN; Prins GS; Bieberich CJ
    Dev Dyn; 2005 Dec; 234(4):961-73. PubMed ID: 16245334
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
    Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
    Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage.
    Bowen C; Zheng T; Gelmann EP
    Cancer Res; 2015 Jul; 75(13):2686-98. PubMed ID: 25977336
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
    Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
    Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
    Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
    Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
    Bowen C; Bubendorf L; Voeller HJ; Slack R; Willi N; Sauter G; Gasser TC; Koivisto P; Lack EE; Kononen J; Kallioniemi OP; Gelmann EP
    Cancer Res; 2000 Nov; 60(21):6111-5. PubMed ID: 11085535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.